4/23/2010 1:59:32 PM
ChinaBio Today -- NeoStem, Inc. announced a stem cell collaboration with ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS). NeoStem will investigate whether Homspera®, ImmuneRegen’s lead product, will enhance stem cell activity when used in combination with NeoStem's VSEL™ technology. More details...
comments powered by